Home   Bookmark and Share
Choose language  
Get the latest info about new FDA drugs medication, side affects, dosage, generic alternative and treatment, prices, sample tablets availiblity and prescription details with news and forum. What is ...? Where can I find, How to buy….? What are side Effects of …. How do I take….Tablet, Pill, Liquid or Capsule, Get it all at DrugsReport.co.uk
 
 
FLECTOR   FLECTOR
 

 


IBSA acronym of Institut Biochimique SA is the privately owned global pharmaceutical company having its headquarters in Lugano, Switzerland. The company is devoted in developing, manufacturing and commercializing the innovative drugs and medicines for various applications.


Out of many of its innovative products, Flector is the inflammatory drug which contains the new IBSA patented Epolamine salt from the well known Diclofenac which is proven for its efficacy in the fields of inflammation as the anti-inflammatory drug, all over the world. When compared with the other standard Diclofenac, the Epolamine salt used in preparing the formulation of Flector granulates applies improvised solubility in both aqueous and lipidic environments. In addition to this, the formulation in the soluble granules assures the faster availability for absorption of the active moiety or half. The end out come is truly the rapid acting anti-inflammatory drug that reaches zenith blood absorption just within the span of fifteen minutes from its administration. Besides this, the zenith absorption is so high that it ensures the increased pain killing properties.

In addition to its great efficacy as the anti-inflammatory treatment, Flector in granulates form is typically indicated for the on-demand or prescription treatment of severe painful conditions such as headaches, toothaches, dysmenorrheal and other similar disorders or conditions. Amongst various advantages of Flector Granulates, a few could be evaluated such as:  the dependability of the anti-inflammatory properties of the efficacy of Diclofenac, very quick on set of actions as well as improved pain killing properties. 

Another product from IBSA in the anti-inflammatory segment is Flector Tissuegel anti-inflammatory plasters prepared with high solubility for effective tissue permeation, which are the unique pharmaceutical products that combine the particular salt called Epolamine of Diclofenac with improvised solubility with the high-tech plaster technologies. The results of this product are effective, safe and convenient local treatment of muscular and typical inflammatory conditions.

Enquiry Field Marked with asterisk (*) are mandatory
Name * Email *
State/Country
Comments *
 

 
 
Currently there are no comments or questions written by any user on "FLECTOR". You can be the First one to write one.
 
 
Kaolin pactin , Lithostet , Ala tat , Milas nervine , Tolneftin , Pime , Meisturin , Nervir , Mexiflor , Bromatap
Latest News About flector
Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for ... - Earthtimes (press release)

Earthtimes (press release), UK - 8 May 2008
FLECTOR(R) Patch has been available since January in the United States for the topical treatment of acute pain due to minor strains, sprains and contusions. ...
Pain Patch Sales Boost Alpharma - Wall Street Journal
Alpharma Reports First Quarter 2008 Revenue Growth of 33% From ... - CNNMoney.com

CNNMoney.com - 5 May 2008
"The successful launch of the FLECTOR® Patch has demonstrated our ability to execute our strategic transformation. In addition, our first quarter ...
Earnings roundup: Drew Industries, Hain Celestial - CNNMoney.com
Monday's Earnings Reports - FOXBusiness

FOXBusiness - 5 May 2008
Pharmaceutical revenue nearly doubled to $66 million, due primarily to the launch of the Flector pain patch in January. Flector patch sales totaled $24.3 ...
Alpharma, Inc. Q1 2008 Earnings Call Transcript - Seeking Alpha

Seeking Alpha, NY - 5 May 2008
Our pharmaceuticals business had strong revenues with growth of 91% in the quarter, given large part to the successful launch of the FLECTOR Patch, ...
Alpharma slips on lower guidance - BusinessWeek
Movers roundup: Albany Molecular Research, PMA Capital - Forbes

Forbes, NY - 5 May 2008
... (nyse: ALO - news - people ) rose Monday after the company reported a huge increase in first-quarter profit following the launch of its pain patch Flector.
Alpharma's Soothing Guidance - Motley Fool

Motley Fool - 16 Apr 2008
Since Alpharma just launched its Flector pain patch in January, it gets a pass in my book on the shaky guidance for 2008, considering that Flector sales are ...
Alpharma Announces Updated Financial Outlook for 2008 - CNNMoney.com

Review of Top Drug
Stores to Buy Drugs

Generic Drugs

4Rx.com
Online Since: 2005
Delivery to: Worldwide except Canada or Mexico.
Ratings & Reviews : *****

XlPharmacy.com
Online Since: 2004
Payment: Visa & Mastercard .
Delivery to: Worldwide
except Canada, Sweden, Germany & Norway

Generic-Pharmacy.net
Online Since: 2002
Languages Supported: English, Italian, Spanish, French
Delivery to: Worldwide
except Germany & Mexico

Brand Drugs

121Doc.com
Online Since: 2003
Languages: English, Italian, Spanish, French, German, Danish, Portuguese, Swiss, Swedish, Deutschl,
Ratings & Reviews: *****

AtlanticDrugs.com
Online Since: 2006
Delivery to: USA and Canada
Affiliate Program Contact Person: Blair Atkinson

SpeedyHealth.com
Online Since: 2006
Drugs Offered: Brand and Generic
Support Options: Email and Phone

GetPharma.com
Drugs Offered: Brand
Payment Options: Visa , Visa Electron, Mastercard
Languages Supported: English, Spanish, Italian, German

eDrugStore.md
Drugs Offered: Brand
Shipping Time: 1-3 Days
Support Options: Email and Phone

drugsreport.co.uk is an independent news website reporting on various new and old drugs developed and marketed by its respective company. Nothing on this website is intended to infringe on any trademark nor any thing on website is intended as medical advice. The information provided here is for informational purposes only. Always consult a medical professional or a doctor with questions you may have regarding a medical condition.